Morgan Stanley’s Ekso Bionics EKSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227 Buy
69
+65
+1,625% +$214 ﹤0.01% 7554
2025
Q1
$25 Hold
4
﹤0.01% 7923
2024
Q4
$39 Hold
4
﹤0.01% 7705
2024
Q3
$72 Sell
4
-5
-56% -$90 ﹤0.01% 7492
2024
Q2
$136 Sell
9
-20
-69% -$302 ﹤0.01% 7318
2024
Q1
$583 Sell
29
-19
-40% -$382 ﹤0.01% 7225
2023
Q4
$1.81K Buy
48
+44
+1,100% +$1.66K ﹤0.01% 7145
2023
Q3
$45 Hold
4
﹤0.01% 7488
2023
Q2
$89 Hold
4
﹤0.01% 7508
2023
Q1
$102 Hold
4
﹤0.01% 7569
2022
Q4
$76 Sell
4
-9
-69% -$171 ﹤0.01% 7713
2022
Q3
$0 Hold
13
﹤0.01% 7738
2022
Q2
$0 Sell
13
-41
-76% ﹤0.01% 7843
2022
Q1
$3K Buy
54
+36
+200% +$2K ﹤0.01% 7679
2021
Q4
$1K Sell
18
-1
-5% -$56 ﹤0.01% 7858
2021
Q3
$1K Sell
19
-325
-94% -$17.1K ﹤0.01% 7768
2021
Q2
$29K Sell
344
-6,345
-95% -$535K ﹤0.01% 6871
2021
Q1
$619K Buy
6,689
+6,670
+35,105% +$617K ﹤0.01% 5034
2020
Q4
$2K Sell
19
-10,222
-100% -$1.08M ﹤0.01% 6889
2020
Q3
$729K Buy
10,241
+10,222
+53,800% +$728K ﹤0.01% 4429
2020
Q2
$2K Sell
19
-297
-94% -$31.3K ﹤0.01% 6445
2020
Q1
$14K Buy
316
+4
+1% +$177 ﹤0.01% 5926
2019
Q4
$27K Buy
312
+5
+2% +$433 ﹤0.01% 6029
2019
Q3
$37K Buy
307
+65
+27% +$7.83K ﹤0.01% 5829
2019
Q2
$69K Sell
242
-61
-20% -$17.4K ﹤0.01% 5483
2019
Q1
$171K Buy
303
+29
+11% +$16.4K ﹤0.01% 5138
2018
Q4
$77K Sell
274
-301
-52% -$84.6K ﹤0.01% 5638
2018
Q3
$302K Buy
575
+556
+2,926% +$292K ﹤0.01% 5262
2018
Q2
$8K Sell
19
-1
-5% -$421 ﹤0.01% 6351
2018
Q1
$7K Sell
20
-11
-35% -$3.85K ﹤0.01% 6337
2017
Q4
$15K Buy
31
+22
+244% +$10.6K ﹤0.01% 6147
2017
Q3
$3K Sell
9
-41
-82% -$13.7K ﹤0.01% 6355
2017
Q2
$26K Buy
50
+28
+127% +$14.6K ﹤0.01% 6032
2017
Q1
$20K Sell
22
-1
-4% -$909 ﹤0.01% 6087
2016
Q4
$20K Buy
23
+7
+44% +$6.09K ﹤0.01% 6006
2016
Q3
$17K Buy
+16
New +$17K ﹤0.01% 5955